We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Investors Undervaluing Elekta (EKTAY) Right Now?
Read MoreHide Full Article
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.
Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.
Elekta (EKTAY - Free Report) is a stock many investors are watching right now. EKTAY is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock holds a P/E ratio of 13.81, while its industry has an average P/E of 32.16. Over the last 12 months, EKTAY's Forward P/E has been as high as 25.06 and as low as 13.49, with a median of 15.99.
Investors should also recognize that EKTAY has a P/B ratio of 2.31. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 4.27. Within the past 52 weeks, EKTAY's P/B has been as high as 3.47 and as low as 2.23, with a median of 2.76.
Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's sales. This is a popular metric because sales are harder to manipulate on an income statement, so they are often considered a better performance indicator. EKTAY has a P/S ratio of 1.35. This compares to its industry's average P/S of 2.94.
Finally, our model also underscores that EKTAY has a P/CF ratio of 10.66. This figure highlights a company's operating cash flow and can be used to find firms that are undervalued when considering their impressive cash outlook. EKTAY's P/CF compares to its industry's average P/CF of 25.45. Within the past 12 months, EKTAY's P/CF has been as high as 14.21 and as low as 10.12, with a median of 11.82.
Another great Medical - Instruments stock you could consider is Tactile Systems Technology (TCMD - Free Report) , which is a # 1 (Strong Buy) stock with a Value Score of A.
Additionally, Tactile Systems Technology has a P/B ratio of 1.79 while its industry's price-to-book ratio sits at 4.27. For TCMD, this valuation metric has been as high as 2.03, as low as 1.28, with a median of 1.69 over the past year.
These are only a few of the key metrics included in Elekta and Tactile Systems Technology strong Value grade, but they help show that the stocks are likely undervalued right now. When factoring in the strength of its earnings outlook, EKTAY and TCMD look like an impressive value stock at the moment.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Investors Undervaluing Elekta (EKTAY) Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.
Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.
Elekta (EKTAY - Free Report) is a stock many investors are watching right now. EKTAY is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock holds a P/E ratio of 13.81, while its industry has an average P/E of 32.16. Over the last 12 months, EKTAY's Forward P/E has been as high as 25.06 and as low as 13.49, with a median of 15.99.
Investors should also recognize that EKTAY has a P/B ratio of 2.31. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 4.27. Within the past 52 weeks, EKTAY's P/B has been as high as 3.47 and as low as 2.23, with a median of 2.76.
Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's sales. This is a popular metric because sales are harder to manipulate on an income statement, so they are often considered a better performance indicator. EKTAY has a P/S ratio of 1.35. This compares to its industry's average P/S of 2.94.
Finally, our model also underscores that EKTAY has a P/CF ratio of 10.66. This figure highlights a company's operating cash flow and can be used to find firms that are undervalued when considering their impressive cash outlook. EKTAY's P/CF compares to its industry's average P/CF of 25.45. Within the past 12 months, EKTAY's P/CF has been as high as 14.21 and as low as 10.12, with a median of 11.82.
Another great Medical - Instruments stock you could consider is Tactile Systems Technology (TCMD - Free Report) , which is a # 1 (Strong Buy) stock with a Value Score of A.
Additionally, Tactile Systems Technology has a P/B ratio of 1.79 while its industry's price-to-book ratio sits at 4.27. For TCMD, this valuation metric has been as high as 2.03, as low as 1.28, with a median of 1.69 over the past year.
These are only a few of the key metrics included in Elekta and Tactile Systems Technology strong Value grade, but they help show that the stocks are likely undervalued right now. When factoring in the strength of its earnings outlook, EKTAY and TCMD look like an impressive value stock at the moment.